MF houses
Aug 20261no change m/m
Top seller Bandhan Mutual Fund, −0.09% of equity. Index and arbitrage funds hidden.
AMC portfolios, Aug 2026 · 20 AMCs trackedSource: AMC monthly portfolios (SEBI disclosure)
1 fund houses →
Artemis Medicare Services Limited
₹357.70NSE close, 25 Sep 2026
Data as of10 sources, each card shows its own date
MF: Aug 2026 portfolios (monthly), 20 AMCsShares outstanding and close: NSE, 25 Sep 2026Delivery: NSE bhavcopy, 25 Sep 2026 · 30 days collectedDeals: NSE deal files, 25 Sep 2026 · collected since 25 Sep 2026SLBM: NSE, 25 Sep 2026 · 30 days collectedMTF: NSE, 24 Sep 2026 · 29 days collectedFlags: NSE, 25 Sep 2026FPI: Shareholding pattern as of 30 Jun 2026, filed 15 Jul 2026Pledge: Shareholding pattern as of 30 Jun 2026Insider: Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)
MF holding, % of equity
0.32%▼ −0.08 pp
Aug 2026 · change vs Jul 2026 over 20 AMCs with both months, all schemes
FPI holding, % of equity
12.28%
as of 30 Jun 2026
Fund houses holding
1no change
0 entered, 0 exited · Aug 2026 · index funds hidden
Promoter pledge
0.00%
as of 30 Jun 2026
What changed
1 tracked fund houses held ARTEMISMED in Aug 2026. None entered or exited.
All tracked schemes together held 5.10 lakh shares, 0.32% of equity, worth ₹16.2 cr at the end of Aug 2026.
Index and arbitrage funds held 0.02% of equity; they are left out of the fund-house counts.
Named FPIs at 1% or more
as of 30 Jun 202612.28%
FPI category I + II, % of total shares · 1 named at 1% or more
FPIs named at 1% or more on 30 Jun 2026: INTERNATIONAL FINANCE CORPORATION 11.98%.
Shareholding pattern as of 30 Jun 2026, filed 15 Jul 2026Source: NSE shareholding pattern filings (XBRL), quarterly
Insider and promoter
29 Jun 2026 to 26 Sep 2026No insider or promoter trade in ARTEMISMED was disclosed 29 Jun 2026 to 26 Sep 2026.
Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)Source: NSE insider trading disclosures (SEBI PIT, XBRL)
Bulk and block deals
25 Sep 2026₹73.5 cr2 deals
Buy side ₹36.7 cr · sell side ₹36.8 cr · both sides as reported
Largest: MICROCURVES TRADING PRIVATE LIMITED sold 10.04 lakh shares at ₹366.15 on 25 Sep 2026, a bulk deal of ₹36.8 cr.
NSE deal files, 25 Sep 2026 · collected since 25 Sep 2026Source: NSE bulk.csv and block.csv, daily
2 deals →
Promoter pledge
as of 30 Jun 20260.00%
of promoter holding · 0.00% of total shares
Promoters had pledged 0 of their 9.24 cr shares on 30 Jun 2026; 4.12 cr encumbered in all (pledge, NDU and other).
Shareholding pattern as of 30 Jun 2026Source: NSE shareholding pattern filings (XBRL), quarterly
SLBM borrowing
25 Sep 2026NSE listed no SLBS open position for ARTEMISMED on any of the 30 days collected, 14 Aug 2026 to 25 Sep 2026. No SLBM trades in ARTEMISMED on 25 Sep 2026.
NSE, 25 Sep 2026 · 30 days collectedSource: NSE SLBS open positions (slb_openpos) and SLBM bhavcopy (SLBM_BC), daily
MTF book
24 Sep 20264.13 lakh sh▼ −5,972 vs 23 Sep 2026
percentile 31 of 29 days collected · ₹13.4 cr financed
4.13 lakh shares, 0.26% of equity in the margin trading book at the end of 24 Sep 2026; that day sits at percentile 31 of 29 days collected.
NSE, 24 Sep 2026 · 29 days collectedSource: NSE margin trading disclosure (mrg_trading), daily
Delivery
25 Sep 20268.2%▼ −37.0 pp vs 20-day average
20-day average 45.2% · percentile 3 of 30 days collected
8.2% of the shares traded on 25 Sep 2026 were delivered, against a 20-day average of 45.2%; that day sits at percentile 3 of 30 days collected.
NSE bhavcopy, 25 Sep 2026 · 30 days collectedSource: NSE security-wise delivery file (sec_bhavdata_full), daily
Red flags
25 Sep 2026No F&O
ARTEMISMED has no F&O contracts in NSE's combined open-interest file, so the F&O ban does not apply. NSE listed ARTEMISMED under no ASM or GSM stage on 25 Sep 2026. Pledge invocations are not collected yet.
NSE, 25 Sep 2026Source: NSE F&O ban file, combined OI (MWPL), surveillance indicators (REG1_IND), daily